PPP1R3C
Protein phosphatase 1 regulatory subunit 3C
Also known as: PPP1R5, PPR3C_HUMAN, PTG
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UQK1
- Gene
- PPP1R3C
- Ensembl
- ENSG00000119938
- Chromosome
- 10
- Canonical length
- 317 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a carbohydrate binding protein that is a subunit of the protein phosphatase 1 (PP1) complex. PP1 catalyzes reversible protein phosphorylation, which is important in a wide range of cellular activities. The encoded protein affects glycogen biosynthesis by activating glycogen synthase and limiting glycogen breakdown by reducing glycogen phosphorylase activity. DNA hypermethylation of this gene has been found in colorectal cancer patients. The encoded protein also interacts with the laforin protein, which is a protein tyrosine phosphatase implicated in Lafora disease. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>Q9UQK1|PPP1R3C
1 MSCTRMIQVL DPRPLTSSVM PVDVAMRLCL AHSPPVKSFL GPYDEFQRRH FVNKLKPLKS
61 CLNIKHKAKS QNDWKCSHNQ AKKRVVFADS KGLSLTAIHV FSDLPEEPAW DLQFDLLDLN
121 DISSALKHHE EKNLILDFPQ PSTDYLSFRS HFQKNFVCLE NCSLQERTVT GTVKVKNVSF
181 EKKVQIRITF DSWKNYTDVD CVYMKNVYGG TDSDTFSFAI DLPPVIPTEQ KIEFCISYHA
241 NGQVFWDNND GQNYRIVHVQ WKPDGVQTQM APQDCAFHQT SPKTELESTI FGSPRLASGL
301 FPEWQSWGRM ENLASYRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP1R3C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 851 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 851 nTPM
- tongue: 419 nTPM
- blood vessel: 171 nTPM
- heart muscle: 160 nTPM
- liver: 157 nTPM
- vagina: 128 nTPM
Single-cell type
- esophageal apical cells: 1,169 nCPM
- myonuclei: 393 nCPM
- müller glia: 227 nCPM
- astrocytes: 140 nCPM
- thymic myoid cells: 78 nCPM
- hepatocytes: 73 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 80 nTPM
- basal ganglia: 71 nTPM
- medulla oblongata: 56 nTPM
- hypothalamus: 55 nTPM
- thalamus: 53 nTPM
- pons: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- glycogen binding
- protein phosphatase 1 binding
- protein phosphatase binding
- protein serine/threonine phosphatase activity
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP1R3C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP1R3C as an antibody target. Whether an autoantibody or antibody against PPP1R3C could matter depends on whether native PPP1R3C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP1R3C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP1R3C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...